LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that it has entered into a note purchase agreement with a fund of Athyrium Capital ...
This chapter describes the technical, economic, and social trends that will drive the development of biotechnology products likely to emerge over the next 5–10 years. Advances in biotechnology, new ...